Abstract
The neurofibromatosis 2 (NF2) tumor suppressor gene product, merlin, belongs to the ezrin–radixin–moesin (ERM) subgroup of the Protein 4.1 family, which links cell surface glycoproteins to the actin cytoskeleton. Previous studies have suggested that phosphorylation of merlin, similar to other ERM proteins, may regulate its function. To determine whether merlin phosphorylation has functional consequences for merlin suppression of cell growth and motility, we generated doxycycline-regulatable RT4 schwannoma cell lines that inducibly express full-length merlin with mutations at two potential phosphorylation sites (amino-acid residues S518 and T576). Whereas a mutation at S518 that mimics constitutive phosphorylation (S518D) abrogates the ability of merlin to suppress cell growth and motility, the S518A merlin mutant, which mimics nonphosphorylated merlin, functions equivalently to wild-type merlin. Similar mutations involving T576, the analogous phosphorylation site in ERM proteins important for regulating their function, had no effect. In contrast to other functionally inactive missense merlin mutants, the regulated overexpression of S518D merlin resulted in dramatic changes in cell shape and the elaboration of filopodial extensions. These results provide the first direct demonstration that the S518D merlin mutation, which mimics merlin phosphorylation, impairs not only merlin growth and motility suppression but also leads to an acquisition of a novel phenotype previously ascribed to ERM proteins.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ackerley S, Thornhill P, Grierson AJ, Brownlees J, Anderton BH, Leigh PN, Shaw CE and Miller CC . (2003). J. Cell. Biol., 161, 489–495.
Baser ME, Evans DG and Gutmann DH . (2003). Curr. Opin. Neurol., 16, 27–33.
Bretscher A, Edwards K and Fehon RG . (2002). Nat. Rev. Mol. Cell. Biol., 3, 586–599.
Bretscher A, Gary R and Berryman M . (1995). Biochemistry, 34, 16830–16837.
Chen J, Cohn JA and Mandel LJ . (1995). Proc. Natl. Acad. Sci. USA, 92, 7495–7499.
Gary R and Bretscher A . (1993). Proc. Natl. Acad. Sci. USA, 90, 10846–10850.
Gary R and Bretscher A . (1995). Mol. Biol. Cell., 6, 1061–1075.
Gautreau A, Louvard D and Arpin M . (2000). J. Cell. Biol., 150, 193–203.
Gautreau A, Louvard D and Arpin M . (2002). Curr. Opin. Cell. Biol., 14, 104–109.
Gautreau A, Poullet P, Louvard D and Arpin M . (1999). Proc. Natl. Acad. Sci. USA, 96, 7300–7305.
Gonzalez-Agosti C, Wiederhold T, Herndon ME, Gusella J and Ramesh V . (1999). J. Biol. Chem., 274, 34438–34442.
Gopalbhai K, Jansen G, Beauregard G, Whiteway M, Dumas F, Wu C and Meloche S . (2003). J. Biol. Chem., 278, 8118–8125.
Gutmann DH, Geist RT, Xu H, Kim JS and Saporito-Irwin S . (1998). Hum. Mol. Genet., 7, 335–345.
Gutmann DH, Haipek CA and Hoang Lu K . (1999). J. Neurosci. Res., 58, 706–716.
Gutmann DH, Hirbe AC and Haipek CA . (2001). Hum. Mol. Genet., 10, 1519–1529.
Henry MD, Gonzalez Agosti C and Solomon F . (1995). J. Cell. Biol., 129, 1007–1022.
Hirao M, Sato N, Kondo T, Yonemura S, Monden M, Sasaki T, Takai Y, Tsukita S and Tsukita S . (1996). J. Cell. Biol., 135, 37–51.
Jabbur JR and Zhang W . (2002). Cancer Biol. Ther., 1, 277–283.
Kissil JL, Johnson KC, Eckman MS and Jacks T . (2002). J. Biol. Chem., 277, 10394–10399.
Martin M, Andreoli C, Sahuquet A, Montcourrier P, Algrain M and Mangeat P . (1995). J. Cell. Biol., 128, 1081–1093.
Martin M, Roy C, Montcourrier P, Sahuquet A and Mangeat P . (1997). Mol. Biol. Cell., 8, 1543–1557.
Matsui T, Maeda M, Doi Y, Yonemura S, Amano M, Kaibuchi K, Tsukita S and Tsukita S . (1998). J. Cell. Biol., 140, 647–657.
Matsui T, Yonemura S, Tsukita S and Tsukita S . (1999). Curr. Biol., 9, 1259–1262.
Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA, Gutmann DH, Ponta H and Herrlich P . (2001). Genes. Dev., 15, 968–980.
Nakamura F, Amieva MR and Furthmayr H . (1995). J. Biol. Chem., 270, 31377–31385.
Ng T, Parsons M, Hughes WE, Monypenny J, Zicha D, Gautreau A, Arpin M, Gschmeissner S, Verveer PJ, Bastiaens PI and Parker PJ . (2001). EMBO J., 20, 2723–2741.
Oshiro N, Fukata Y and Kaibuchi K . (1998). J. Biol. Chem., 273, 34663–34666.
Pietromonaco SF, Simons PC, Altman A and Elias L . (1998). J. Biol. Chem., 273, 7594–7603.
Rouleau GA, Merel P, Luchtman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk M, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, de Jong P, Parry D, Eldridge R, Aurias A, Delattre O and Thomas G . (1993). Nature, 363, 515–521.
Shaw RJ, Henry M, Solomon F and Jacks T . (1998a). Mol. Biol. Cell., 9, 403–419.
Shaw RJ, McClatchey AI and Jacks T . (1998b). J. Biol. Chem., 273, 7757–7764.
Shaw RJ, Paez JG, Curto M, Yaktine A, Pruitt WM, Saotome I, O'Bryan JP, Gupta V, Ratner N, Der CJ, Jacks T and McClatchey AI . (2001). Dev. Cell, 1, 63–72.
Sherman L, Xu HM, Geist RT, Saporito-Irwin S, Howells N, Ponta H, Herrlich P and Gutmann DH . (1997). Oncogene, 15, 2505–2509.
Sherman LS and Gutmann DH . (2001). Trends Cell Biol., 11, 442–444.
Tran Quang C, Gautreau A, Arpin M and Treisman R . (2000). EMBO J., 19, 4565–4576.
Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyai MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckner AJ and Gusella JF . (1993). Cell, 72, 791–800.
Tsukita S, Oishi K, Sato N, Sagara J, Kawai A and Tsukita S . (1994). J. Cell. Biol., 126, 391–401.
Tsukita S, Yonemura S and Tsukita S . (1997). Trends Biochem. Sci., 22, 53–58.
Xiao GH, Beeser A, Chernoff J and Testa JR . (2002). J. Biol. Chem., 277, 883–886.
Xu HM and Gutmann DH . (1998). J. Neurosci. Res., 51, 403–415.
Yonemura S, Tsukita S and Tsukita S . (1999). J. Cell. Biol., 145, 1497–1509.
Acknowledgements
We thank the members of our laboratory for their insightful comments during the execution of these experiments. We thank Dr Joseph Testa (Fox Chase Cancer Center, Philadelphia, PA, USA) for the original S518 mutant clones and Dr Stefan Pulst (Cedars Sinai Medical Center, Los Angeles, CA, USA) for the GST-βII-spectrin fragment. This work was funded by a grant by the National Institutes of Health (NS35848) to DHG.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Surace, E., Haipek, C. & Gutmann, D. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function. Oncogene 23, 580–587 (2004). https://doi.org/10.1038/sj.onc.1207142
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207142